Psivida Announces Future Out-Licensing of BioSilicon

Global nanotechnology company Psivida has announced it has signed an agreement with U.S.-based PureTech Development to investigate and evaluate out-licensing opportunities for BioSilicon with an emphasis on tissue engineering, wound management and orthopedics.

nanotechwire.com (http://nanotechwire.com/news.asp?nid=1683)